Phibro Animal Health Corporation Reports First Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Phibro Animal Health (PAHC) Misses Q1 EPS by 5c, Revenues Miss; Reaffirms Previous FY Guidance
November 4, 2019 4:50 PM ESTPhibro Animal Health (NASDAQ: PAHC) reported Q1 EPS of $0.19, $0.05 worse than the analyst estimate of $0.24. Revenue for the quarter came in at $190 million versus the consensus estimate of $199.67 million.
Highlights for the September 2019 quarter (compared to the September 2018 quarter)
Net sales of $190 million, a decrease of $10 million, or 5%Net income of $3 million, a decrease of $14 million, or 85%Diluted EPS of $0.06, a decrease of $0.34, or 85%Adjusted EBITDA of $20 million, a decrease of $10 million, or 35%Adjusted diluted EPS of $0.19, a decrease of $0.20, or... More